The Indian government has officially banned medical representatives (MRs) from meeting doctors in government hospitals, aiming to curb unethical influence and promote unbiased clinical decisions. Read full story on MBT.
The move, enforced by the Directorate General of Health Services (DGHS), mandates digital-only communication between pharmaceutical reps and hospital staff. Proponents argue it ensures patient care isn’t compromised by promotional pressure. Critics claim it could hamper timely medical updates and professional networking.
What’s your take?
- Will this improve transparency and patient-first care?
- Should this also apply to private hospitals?
- Could the lack of face-to-face interaction delay awareness about new drugs or therapies?
- Are MRs really part of the problem, or is this an oversimplified fix?
- Do you support the ban on MRs in govt hospitals?
- Yes – It will reduce bias and protect clinical integrity
- No – It limits access to valuable scientific updates
- Mixed feelings – Needs better regulation, not a total ban
Whether you’re a doctor, student, pharma professional, or policymaker—your perspective matters in this evolving healthcare debate. Join in!